Anavex Life Sciences Corp. ( AVXL) - Stock Earnings
AVXL Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 10, 2026, midnight | — / — | — | — / — | — |
AVXL Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -9.8 million USD | — USD |
| 2025Q4 | -5.7 million USD | — USD |
| 2026Q1 | -5.3 million USD | — USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
AVXL Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -47.5 million USD | — USD |
| 2024 | -43.0 million USD | — USD |
| 2025 | -46.4 million USD | — USD |
| 2026 Est. | — | — |
AVXL
Price: $3.22
52 week price:
Earnings Per Share: -0.39 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 1.1 million
Ebitda: -4.1 millionMarket Capitalization: 316.1 million